Park National Corp /oh/ reports 39.21% decrease in ownership of GSK / GlaxoSmithKline plc
July 02, 2018 - Park National Corp /oh/ has filed a 13F-HR form disclosing ownership of 6,367 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $256,000 USD as of June 30, 2018. Park National Corp /oh/ had filed a previous 13F-HR on April 02, 2018 disclosing 10,474 shares of GlaxoSmithKline plc at a value of $410,000 USD. This represents a change in shares of -39.21 percent and a change in value of -37.56 percent during the quarter.
Other investors with positions similar to Park National Corp /oh/ include Quadrant Capital Group Llc, General Re New England Asset Management Inc, Koshinski Asset Management, Inc., Fintrust Investment Advisory Services, Llc, Perigon Wealth Management, LLC, and Weil Company, Inc..
The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.
In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.
Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.
|GlaxoSmithkline PLC Sponsored||Com||37733W105||39.68||6,367||-39.21||256||-37.56||-163||9||2.18|
|GlaxoSmithkline PLC Sponsored||Com||37733W105||37.29||10,474||26.24||410||39.46||81||35||11.84|
|GlaxoSmithkline PLC Sponsored||Com||37733W105||38.01||8,297||-9.22||294||-20.75||-32||-45||-12.12|
|GlaxoSmithkline PLC Sponsored||Com||37733W105||41.84||9,140||2.27||371||-3.64||8||-22||-5.84|
|GlaxoSmithkline PLC Sponsored||Com||37733W105||42.60||8,937||41.54||385||44.74||112||7||2.73|
|GlaxoSmithkline PLC Sponsored||Com||37733W105||40.27||6,314||1.90||266||11.76||5||23||9.77|
|GlaxoSmithkline PLC Sponsored||Com||37733W105||40.73||6,196||-8.36||238||-18.21||-23||-30||-10.31|
|GlaxoSmithkline PLC Sponsored ADR||Equity||37733W105||43.20||6,761||2.52||291||1.75||7||-2||-0.76|
|GlaxoSmithkline PLC Sponsored ADR||Equity||37733W105||41.99||6,595||-4.70||286||1.78||-14||19||6.64|
as of ET